SmartBio Analytics supports pharmaceutical companies with fast, reliable and regulatory-ready bioanalytical services. Our expertise helps accelerate drug development through high-quality analytical data and scientific support.
We support projects from early discovery to late-stage clinical trials and bioequivalence studies, adapting our workflows to your project’s priorities — whether it’s accelerating method development in the preclinical phase or ensuring full traceability and compliance in regulated studies.
Method development and validation for novel molecules, supporting PK/TK, biodistribution, and biomarker analysis.
Bioequivalence and comparative PK studies with rapid turnaround times.
Analytical characterization for formulation optimization.
Method development in 1–2 weeks, validation in 4–6 weeks, analysis results in ≤ 5 days
Full compliance with QA & Certifications standards for FDA, EMA, and OECD acceptance
From small molecules to complex biomolecules including peptides, oligonucleotides, lipids, and proteins
We work as an extension of your R&D team, adapting to your timelines and needs
Meet our scientists on the Team page
With SmartBio Analytics, you gain a bioanalytical partner who can keep pace with your development timelines while ensuring the quality and reliability your regulatory submissions demand.
